9 September 2023 | Product and Promotions Guide
Managing Joint Disease
The same measures used to prevent joint disease can
aid in managing osteoarthritis. In addition to weight loss,
lifestyle changes, and supplements, there are a number of
other treatment options to consider:
• Non-steroidal anti-inflammatory drugs (NSAIDs),
including phenylbutazone, flunixin, ketoprofen, and
firocoxib
• Polysulfated glycosaminoglycans (PSGAGs)
• Intra-articular corticosteroid injections
• Regenerative medicine, such as PRP
• Surgical interventions, such as arthrodesis.
Each of these treatment options has unique pros and
cons. For example, NSAIDs may be associated with
gastrointestinal effects, while intraarticular injections
can lead to septic arthritis and other adverse effects on
cartilage. Through education and open communication,
you and your client can arrive at the best possible
treatment plan for their individual horse.
Conclusion
Joint health plays a key role in equine practice. Take the
time to develop a conscious, intentional joint care program
for each patient, ranging from performance horses to
backyard pasture pets.
Taking a proactive approach to joint health during a horse's
early years, educating clients on weight management,
lifestyle factors, and the effective use of supplements, can
help reduce discomfort and reduce the need for treatment
of symptomatic joint disease, while also creating a
valuable profit center for your practice.
About the author Cathy Barnette, DVM is a
veterinarian and freelance writer, based in Southwest Florida.
After graduating from the University of Florida in 2006,
Dr. Barnette spent 14 years working in small animal general
practice. Her current professional focus is veterinary writing,
creating educational content for veterinary teams and their
clients. Dr. Barnette is a paid Consultant for Covetrus®.
1. Paris, A., Beccati, F., & Pepe, M. (2021). Type, prevalence, and risk factors for the development of orthopedic injuries in endurance horses during training and competition. Journal of the
American Veterinary Medical Association, 258(10), 1109–1118. Retrieved from: https://avmajournals.avma.org/view/journals/javma/258/10/javma.258.10.1109.xml
2. Baccarin, R. Y. A., Seidel, S. R. T., Michelacci, Y. M., Tokawa, P. K. A., & Oliveira, T. M. (2022). Osteoarthritis: a common disease that should be avoided in the athletic horse's life. Animal frontiers:
the review magazine of animal agriculture, 12(3), 25–36. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197312/
3. Lenz, T. Obesity. American Association of Equine Practitioners. Retrieved from: https://aaep.org/horsehealth/obesity
4. Swirsley, N., Spooner, H., & Hoffman, R. (2017). Supplement Use and Perceptions: A Study of US Horse Owners. Journal of Equine Veterinary Science, 59: 34-39. Retrieved from: https://www.
sciencedirect.com/science/article/abs/pii/S073708061730028X
5. Oke, S., Aghazadeh-Habashi, A., Weese, J. S., & Jamali, F. (2006). Evaluation of glucosamine levels in commercial equine oral supplements for joints. Equine veterinary journal, 38(1), 93–95.
